Patient guides & resources to accessing medicinal cannabis Medicinal cannabis information for Australia is scattered and hard to find, Each. Medicinal cannabis: Patient information. Over the past few years there has been increased interest from Australians in the use of cannabis for medicinal purposes. . For more resources and further information about medicinal cannabis go Sitemap · A-Z guide · Contact the TGA · Freedom of Information. On this page: Medicinal cannabis: patient information | The evidence | Access Johansen and Thomsen , Review Article - Guidelines for.
& information – cannabis Medicinal guides Australia resources Patient
The prescribing and dispensing of medicinal cannabis products under specific circumstances is now legal in Australia. The cultivation and manufacture of medicinal cannabis products have also been legalised by the Commonwealth, and in some cases, State and Territory governments. The term medicinal marijuana refers to treating a disease or its symptoms with the whole unprocessed marijuana plant or its basic extracts. There are more than chemical compounds in marijuana; of them are cannabinoids, which are the active ingredients in cannabis cannabis is how marijuana is referred to when it is in plant form.
THC is probably best known for being the psychoactive ingredient in marijuana which creates the feeling of being 'high'. THC may also be responsible for some of the medicinal effects of cannabis such as reduction of nausea, vomiting, pain and muscle spasms as well as improvements in sleep and appetite. CBD is non-psychoactive and therefore, cannot make you high.
While disappointing to recreational users, this unique feature of CBD is what makes it so appealing as a medicine. Evidence suggests it may be useful in the management of seizures and pain. Medicinal cannabis products with the exception of nabiximols are not registered on the Australian Register of Therapeutic Goods ARTG and are not available as registered prescription medicines. Products similar to those available through import from Canada and Europe are being manufactured from locally grown medicinal cannabis and are expected to become available in Australia during Compliance to conditions of any licence is mandatory.
A medical practitioner or pharmacist may also import cannabis medicines where the supply is authorised under the Poisons and Therapeutic Goods Act and approved by the Commonwealth to access unregistered cannabis medicines.
After submission of the completed form, the applicant will be provided with a written acknowledgement of the application. The acknowledgement will include a request for omitted or incomplete documents if required. Once all documents have been received, assessment of the application will take place and a recommendation will be made to either grant or refuse the application.
If the recommendation is to approve the granting of the licence, the licence will be issued to the applicant. If the recommendation is to refuse the granting of the licence the reasons for the refusal will be provided to the applicant.
For further information on the application process see the website of the Regulation and Compliance Unit. Some products may require refrigeration and information on storage details is available.
Patients who believe a cannabis medicine may be helpful to their condition should consult their General Practitioner for advice. For further information patients may contact the Centre for Medicinal Cannabis Research and Innovation. Cannabis medicines supplied in or from NSW other than when dispensed to a patient must be packaged and labelled as Schedule 8 drugs unless a Schedule 4 cannabidiol product , unless otherwise exempted by the Secretary, NSW Health.
For general enquiries, contact: Patients and members of the public can also call the Cannabis Medicines help line toll free within Australia Phone: For medical practitioner and other health practitioner enquiries about using a cannabis medicine to treat a patient, contact: For medical practitioner enquiries about authorisations to prescribe, contact: For enquiries relating to the importation, cultivation, production and manufacture of cannabis medicines, contact:.
The Office of Drug Control Phone: A to Z Feedback Contact us Emergency information. Home Pharmaceutical services Cannabis medicines Cannabis medicines. Pharmaceutical services Currently selected Medical practitioners Pharmacists Patients and consumers Licences and authorisations.
Requirements on the prescriber To prescribe and supply a Schedule 8 cannabis medicine, the prescriber must: Companies with exsiting wholesale licences for Schedule 8 drugs need to apply to NSW Health for amendment of their licence in order to supply cannabis medicines, and must provide a revised procedure which may include refrigerated storage of Schedule 8 products, where required.
Separate premises, capable of complying with the provisions of the Australian Code of Good Wholesaling Practice for Medicines in Schedules 2, 3, 4 and 8 are required.
Developed by recognized cannabis expert Dr. Eternal Plants writes about the benefits of hemp cbd oil and medicinal cannabis. We want to educate our customers and help spread the message about this miracle plant. Your email address will not be published. Subscribe to our newsletter. Your Privacy is protected.
We only send useful and relevant information, education and news. You can unsubscribe any time. GPs can assist specialist with ongoing prescriptions. Eternal Plants Eternal Plants writes about the benefits of hemp cbd oil and medicinal cannabis. Why so few Australians are using medicinal cannabis on prescription.
Leave a Reply Cancel reply Your email address will not be published. Join Our Mailing List.
Medicinal cannabis (medical marijuana) is highly regulated in Australia. and Guidance), Queensland Health (Patient guide to accessing medicinal cannabis), . Patients in South Australia can access medicinal cannabis medicines as a result of federal legislative changes which came into effect in November and the. Is there a list of doctors who can prescribe medicinal cannabis? . Exemptions apply in South Australia for patients aged over 70 years of age.